Story perspectives

Strategy Retains Nasdaq Spot Amid Bitcoin Accumulation Debate

12/14/2025

Summary

Story summary

Strategy (NASDAQ: MSTR) will retain its Nasdaq 100 position after the annual rebalancing, effective December 22, 2025.
Analysts question whether Strategy's bitcoin accumulation resembles an investment fund rather than a technology company.
The rebalancing will remove six companies, including Biogen and Lululemon, and add new entrants Alnylam Pharmaceuticals and Seagate Technology.
MSCI will decide in January whether to exclude Strategy from its indexes, which could affect its market presence.

1 of 1

Story summary

Strategy (NASDAQ: MSTR) will retain its Nasdaq 100 position after the annual rebalancing, effective December 22, 2025.
Analysts question whether Strategy's bitcoin accumulation resembles an investment fund rather than a technology company.
The rebalancing will remove six companies, including Biogen and Lululemon, and add new entrants Alnylam Pharmaceuticals and Seagate Technology.
MSCI will decide in January whether to exclude Strategy from its indexes, which could affect its market presence.